logo
logo

Centerline Biomedical Raises $33 Million In Series B Financing

Jun 27, 2022•about 3 years ago

Amount Raised

$33 Million

Round Type

series b

Cleveland

Description

Centerline Biomedical, Inc. (Centerline), a private medical technology company, announced the closing of a $33 million Series B equity financing led by Cleveland Clinic with participation by GE Healthcare, RIK Enterprises, JobsOhio, Jumpstart Ventures and G2 Group Ventures. This funding will help propel the company into new surgical applications, accelerate its commercial sales and add to its growing clinical evidence repository.

Company Information

Company

Centerline Biomedical

Location

Cleveland, Ohio, United States

About

Centerline Biomedical, Inc. was founded in 2014 as a spinoff of the Cleveland Clinic to commercialize our innovative vascular navigation technology. With a research, development, and design history rooted in the Clinic’s world-class Lerner Research Institute’s Heart and Vascular Institute, the IOPS™ platform can be further used for predictive modeling, clinical decision support, global healthcare analytics and the education and training of future surgeons and interventionists.

Related People

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech